Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2081816252', 'doi': 'https://doi.org/10.1625/jcam.1.17', 'title': 'Randomized Controlled Trials for Creating Scientific Evidence of the Efficacy and Safety of Complementary and Alternative Medicine', 'display_name': 'Randomized Controlled Trials for Creating Scientific Evidence of the Efficacy and Safety of Complementary and Alternative Medicine', 'publication_year': 2004, 'publication_date': '2004-01-01', 'ids': {'openalex': 'https://openalex.org/W2081816252', 'doi': 'https://doi.org/10.1625/jcam.1.17', 'mag': '2081816252'}, 'language': 'ja', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1625/jcam.1.17', 'pdf_url': 'https://www.jstage.jst.go.jp/article/jcam/1/1/1_1_17/_pdf', 'source': {'id': 'https://openalex.org/S13219930', 'display_name': 'Japanese Journal of Complementary and Alternative Medicine', 'issn_l': '1348-7922', 'issn': ['1348-7922', '1348-7930'], 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://www.jstage.jst.go.jp/article/jcam/1/1/1_1_17/_pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5033942365', 'display_name': 'Toshiro Tango', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Toshiro Tango', 'raw_affiliation_strings': ['Department of Technology Assessment and Biostatistics, National Institute of Public Health'], 'affiliations': [{'raw_affiliation_string': 'Department of Technology Assessment and Biostatistics, National Institute of Public Health', 'institution_ids': []}]}], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5033942365'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': '1', 'issue': '1', 'first_page': '17', 'last_page': '29'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10804', 'display_name': 'Health Economics and Quality of Life Assessment', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10804', 'display_name': 'Health Economics and Quality of Life Assessment', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T11235', 'display_name': 'Statistical Methods in Clinical Trials and Drug Development', 'score': 0.9959, 'subfield': {'id': 'https://openalex.org/subfields/2613', 'display_name': 'Statistics and Probability'}, 'field': {'id': 'https://openalex.org/fields/26', 'display_name': 'Mathematics'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T10206', 'display_name': 'Methods for Evidence Synthesis in Research', 'score': 0.994, 'subfield': {'id': 'https://openalex.org/subfields/1804', 'display_name': 'Statistics, Probability and Uncertainty'}, 'field': {'id': 'https://openalex.org/fields/18', 'display_name': 'Decision Sciences'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/multiple-testing', 'display_name': 'Multiple Testing', 'score': 0.499367}], 'concepts': [{'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.97004247}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5397092}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.14588714}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1625/jcam.1.17', 'pdf_url': 'https://www.jstage.jst.go.jp/article/jcam/1/1/1_1_17/_pdf', 'source': {'id': 'https://openalex.org/S13219930', 'display_name': 'Japanese Journal of Complementary and Alternative Medicine', 'issn_l': '1348-7922', 'issn': ['1348-7922', '1348-7930'], 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1625/jcam.1.17', 'pdf_url': 'https://www.jstage.jst.go.jp/article/jcam/1/1/1_1_17/_pdf', 'source': {'id': 'https://openalex.org/S13219930', 'display_name': 'Japanese Journal of Complementary and Alternative Medicine', 'issn_l': '1348-7922', 'issn': ['1348-7922', '1348-7930'], 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 2, 'referenced_works': ['https://openalex.org/W2045127388', 'https://openalex.org/W2147581820'], 'related_works': ['https://openalex.org/W4389568370', 'https://openalex.org/W3108674512', 'https://openalex.org/W3032375762', 'https://openalex.org/W3031052312', 'https://openalex.org/W2748952813', 'https://openalex.org/W2586801360', 'https://openalex.org/W2080531066', 'https://openalex.org/W1995515455', 'https://openalex.org/W1506200166', 'https://openalex.org/W1489783725'], 'abstract_inverted_index': {'無作為化比較試験(RCT,': [0], 'randomized': [1], 'controlled': [2], 'trial)が新しい治療法の効果を評価するためにヒトに施される実験であり,かつまた,それが最も質の高い科学的なエビデンスを提供してくれる唯一の研究デザインであることは世界的に広く認められた事実である.一方,日本では,RCT': [3], 'に対する関心とその重要性への認識は低く,薬効評価の分野でも質の高い': [4], 'RCT': [5, 7], 'はきわめて少なかった.最近の科学的根拠に基づく医療(EBM)の流行により': [6], 'に対する関心は高まっているものの,RCT': [8], 'を正しく理解して実践できる臨床医,製薬メーカの臨床開発担当者は少ない.このことは補完代替医療の評価においても全く同様にあてはまる.RCT': [9], 'を正しく理解し,デザインし,その結果を正しく評価できる研究者,実務家の養成は急務である.本小論では,RCT': [10], 'とは何か,RCT': [11], 'をデザインする上で必要不可欠な統計学的考え方を解説する.': [12]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2081816252', 'counts_by_year': [], 'updated_date': '2024-08-27T04:24:26.022313', 'created_date': '2016-06-24'}